Suarez F L, Zumarraga L M, Furne J K, Levitt M D
Ross Products Division, Abbott Laboratories, Columbus, Ohio, USA.
J Am Diet Assoc. 2001 Dec;101(12):1447-52. doi: 10.1016/S0002-8223(01)00349-2.
To determine if ingestion of 2 doses of milk-based dietary supplements produce gaseous symptoms in subjects who malabsorb lactose.
Randomized, controlled, crossover trial.
SUBJECTS/SETTING: Ten community-based subjects who malabsorb lactose.
Ingestion of 2 standard servings of milk-based supplements (a powder reconstituted in fat-free milk or a ready-to-drink preparation) or low-lactose control preparations.
Frequency of flatus passage and subjective impression of bloating, flatulence, and abdominal discomfort.
Wilcoxon signed-rank test.
The high lactose content (27 g) of 2 servings of the powder-based supplement ingested without other food resulted in a marked increase in daily flatus passages from the basal level of 9.7+/-8.2 to 30+/-14 (mean+/-SD), and a significant increase in the subjects' perception of gas. In contrast, the lower lactose content (18.4 g) of 2 servings of a ready-to-drink supplement resulted in a flatus frequency of 17+/-10 (P=.14 vs baseline) and no significant increase in the perception of increased gas. Neither supplement resulted in a significant increase in bloating, abdominal pain, or diarrhea. The lactose content of the liquid supplement was reduced by 80% following overnight incubation with an over-the-counter lactase preparation.
APPLICATIONS/CONCLUSIONS: Persons who malabsorb lactose should be aware that sizable increases in rectal gas commonly occur when milk-based powders reconstituted in milk are used as meal replacements. In contrast, gas problems probably will be minor following ingestion of 2 doses of a ready-to-drink, milk-based supplement. The lactose content of these supplements can be markedly reduced by overnight incubation with over-the-counter lactase preparations, and this manipulation should be beneficial for subjects troubled by the increased gas caused by the consumption of lactose-containing supplements.
确定摄入两剂乳基膳食补充剂是否会在乳糖吸收不良的受试者中产生气体相关症状。
随机、对照、交叉试验。
受试者/研究地点:10名社区乳糖吸收不良受试者。
摄入两标准份乳基补充剂(一种用无脂牛奶复溶的粉末或即饮制剂)或低乳糖对照制剂。
排气频率以及腹胀、肠胃胀气和腹部不适的主观感受。
Wilcoxon符号秩检验。
在未摄入其他食物的情况下,摄入两剂粉末状补充剂的高乳糖含量(27克)导致每日排气次数从基础水平的9.7±8.2显著增加至30±14(均值±标准差),且受试者对气体的感知显著增加。相比之下,两剂即饮补充剂较低的乳糖含量(18.4克)导致排气频率为17±10(与基线相比P = 0.14),且气体感知无显著增加。两种补充剂均未导致腹胀、腹痛或腹泻显著增加。液体补充剂与一种非处方乳糖酶制剂过夜孵育后,乳糖含量降低了80%。
应用/结论:乳糖吸收不良者应意识到,当用牛奶复溶的乳基粉末用作代餐时,直肠气体通常会大幅增加。相比之下,摄入两剂即饮乳基补充剂后,气体问题可能较小。这些补充剂的乳糖含量可通过与非处方乳糖酶制剂过夜孵育而显著降低,这种处理方法应对因食用含乳糖补充剂导致气体增加而困扰的受试者有益。